文献速递角膜与眼表疾病

I型波士顿人工角膜植入对视觉相关生活质量的影响

Impact of type I Boston keratoprosthesis implantation on vision-related quality of life.
PubMed 文献 · Br J Ophthalmol · 2017-09-19

前瞻性研究纳入33例双眼角膜盲患者,在单一三级眼科医院接受I型波士顿人工角膜(KPro)植入,采用视觉损伤影响问卷(IVI)在术前和术后3-6个月评估视觉相关生活质量(VRQoL)。Rasch分析显示阅读、移动和情绪三个分量表均获改善,效应量分别为0.88、0.89和0.59,情绪改善可能不完全由视力提高解释。

要点

  • 双眼角膜盲患者KPro植入后3-6个月,阅读和移动能力获大幅改善(效应量0.88和0.89)。
  • 情绪分量表获中度改善(效应量0.59),可能不完全由视力提高解释。
  • 器械保留率90%,平均随访26±12个月。

核心结论

  • KPro植入后VRQoL出现差异性短期改善,对情绪健康有显著影响,可能不完全由视力改善解释。
  • 需进一步研究确认这些VRQoL改善能否长期维持并推广至其他人群。

研究设计与样本

  • 前瞻性研究,纳入33例双眼角膜盲患者(平均年龄56±12岁,67%男性),于2011年6月至2015年7月在单一三级眼科医院接受KPro植入。
  • 采用IVI问卷在基线及术后3-6个月(最佳矫正视力稳定后)评估VRQoL,Rasch分析转化为阅读、移动和情绪三个分量表的等距测量值并计算效应量。

主要发现

  • 术前手术眼平均BCVA为2英尺数指(对侧眼20/240)。
  • 术前VRQoL评分:阅读-2.27 logits、移动-2.91 logits、情绪-3.06 logits。
  • 器械保留率90%,平均随访26±12个月。
  • 阅读改善1.92 logits(效应量0.88),移动改善2.64 logits(效应量0.89),情绪改善2.11 logits(效应量0.59)。
  • 多因素分析中这些改善与BCVA无显著关联(所有p>0.05)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 需进一步研究确认VRQoL改善能否长期维持并推广至其他人群。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: To determine the impact of type I Boston keratoprosthesis (KPro) implantation on vision-related quality of life (VRQoL). METHODS: Prospective study in 33 patients (mean age 56±12 years, 67% male) with bilateral corneal blindness, who underwent a KPro implantation at a single tertiary eye hospital (June 2011-July 2015). VRQoL was evaluated using the Impact of Vision Impairment Questionnaire (IVI) at baseline and at 3-6 months postsurgery, after stabilisation of best-corrected visual acuity (BCVA). Rasch analysis was used to transform the IVI responses into interval-level measures comprising the 'reading', 'mobility' and 'emotional' subscales with effect sizes calculated for pre-post VRQoL scores. RESULTS: Mean preoperative BCVA was counting-fingers at 2 feet in the operated eye (20/240 fellow eye). Preoperative VRQoL scores: -2.27, -2.91 and -3.06 logits for the reading, mobility and emotional subscales, respectively. Device retention rate was 90% over the follow-up period (mean 26±12 months). We observed large gains for reading and mobility of 1.92 logits (effect size 0.88), and 2.64 logits (effect size 0.89) respectively, with a moderate gain in the emotional subscale of 2.11 logits (effect size 0.59). These improvements did not vary significantly with BCVA on multivariate analysis (all p>0.05). CONCLUSION: We observed a differential short-term improvement to VRQoL after KPro implantation with a significant impact on emotional well-being, which may not be fully explained by visual improvement alone. Further studies are required to confirm if these improvements in VRQoL are sustained in the long-term and are generalisable to other populations.

来源:Br J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Ang M, Man R, Fenwick E, et al. Impact of type I Boston keratoprosthesis implantation on vision-related quality of life. Br J Ophthalmol. 2017. PMID: 28928267. doi:10.1136/bjophthalmol-2017-310745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。